Infliximab BS IV infusion 100mg “Pfizer” is a biosimilar containing infliximab (genetical recombination) [infliximab follow-up 3]. It is manufactured by Pfizer and is used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and psoriasis. It is supplied as 100mg x 1 bottle with YJ code 2399406F1024.
Infliximab BS IV infusion 100mg “Pfizer”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →